4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-18-010837
Chief Technology Officer & EVP sold 14,279 shares at $7.58 ($108,266)
From the SEC's structured data for this filing
Trades in this filing
Aunins John G. · Chief Technology Officer & EVP
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-04-25 | Sale : show line 1 in the form | −14,279 | $7.58 | $108,266 | 184,485 | D |
| Open-market sales · 14,279 sh · avg $7.58 · $108,266 | ||||||
Loading xslF345X03/doc4.xml…